Shopping Cart
- Remove All
- Your shopping cart is currently empty
p-Hydroxycinnamic acid (NSC-59260) can inhibit platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 g | $29 | In Stock |
Description | p-Hydroxycinnamic acid (NSC-59260) can inhibit platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively. |
Targets&IC50 | Prostaglandin E2:126 μM, TXB2:371 μM |
In vitro | p-Hydroxycinnamic acid (500 μM and 1 mM) reduces ADP-induced platelet aggregation (55?2 (SE 4?01) % and 35?6 (SE 2?35) % relative to the basal level, respectively). p-Hydroxycinnamic acid is able to modify platelet function, a shear-inducing device that simulates primary hemostasis. p-Hydroxycinnamic acid interferes also with arachidonic acid cascade, reducing thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation (IC50 371 and 126 μM, respectively)[1]. |
Alias | p-Hydroxy-cinnamic acid, p-Cumaric acid, p-Coumaric acid, NSC 59260 |
Molecular Weight | 164.16 |
Formula | C9H8O3 |
Cas No. | 7400-08-0 |
Smiles | C(=CC(O)=O)C1=CC=C(O)C=C1 |
Relative Density. | 1.329 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 6.25 mg/mL (38.07 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.